A role for p21 (WAF1) in the cAMP-dependent differentiation of F9 teratocarcinoma cells into parietal endoderm

Experimental Cell Research

Volumn 304, Issue 1, 2005, Pages 293-304

  Drdová, Blanka ^a   Vachtenheim, Jiri ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

cAMP; Cip1; F9; p21; Parietal endoderm; Retinoid acid; Teratocarcinoma; WAF1

Indexed keywords

BUCLADESINE; COMPLEMENTARY DNA; CYCLIC AMP; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN E; HYBRID PROTEIN; MESSENGER RNA; MUTANT PROTEIN; PROTEIN P300; RETINOIC ACID; SMALL INTERFERING RNA; THROMBOMODULIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CELL CLONE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL FRACTIONATION; CONTROLLED STUDY; CYTOPLASM; ENDODERM; GENETIC TRANSFECTION; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; TERATOCARCINOMA; UPREGULATION;

EID: 13544268502     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2004.10.027     Document Type: Article

References (56)

1. S. Strickland, K.K. Smith, and K.R. Marotti Hormonal induction of differentiation in teratocarcinoma stem cells: generation of parietal endoderm by retinoic acid and dibutyryl cAMP Cell 21 1980 347 355
2. H. Chiba, J. Clifford, D. Metzger, and P. Chambon Specific and redundant functions of retinoid X Receptor/Retinoic acid receptor heterodimers in differentiation, proliferation, and apoptosis of F9 embryonal carcinoma cells J. Cell Biol. 139 1997 735 747
3. C. Rochette-Egly, and P. Chambon F9 embryocarcinoma cells: a cell autonomous model to study the functional selectivity of RARs and RXRs in retinoid signaling Histol. Histopathol. 16 2001 909 922
4. J. Clifford, H. Chiba, D. Sobieszczuk, D. Metzger, and P. Chambon RXRalpha-null F9 embryonal carcinoma cells are resistant to the differentiation, anti-proliferative and apoptotic effects of retinoids EMBO J. 15 1996 4142 4155
5. C. Rochette-Egly, J.L. Plassat, R. Taneja, and P. Chambon The AF-1 and AF-2 activating domains of retinoic acid receptor-alpha (RARalpha) and their phosphorylation are differentially involved in parietal endodermal differentiation of F9 cells and retinoid-induced expression of target genes Mol. Endocrinol. 14 2000 1398 1410
6. R. Taneja, C. Rochette-Egly, J.L. Plassat, L. Penna, M.P. Gaub, and P. Chambon Phosphorylation of activation functions AF-1 and AF-2 of RAR alpha and RAR gamma is indispensable for differentiation of F9 cells upon retinoic acid and cAMP treatment EMBO J. 16 1997 6452 6465
7. H. Kawasaki, R. Eckner, T.P. Yao, K. Taira, R. Chiu, D.M. Livingston, and K.K. Yokoyama Distinct roles of the co-activators p300 and CBP in retinoic-acid-induced F9-cell differentiation Nature 393 1998 284 289
8. D. Chakravarti, V.J. LaMorte, M.C. Nelson, T. Nakajima, I.G. Schulman, H. Juguilon, M. Montminy, and R.M. Evans Role of CBP/P300 in nuclear receptor signalling Nature 383 1996 99 103
9. A.S. Espeseth, S.P. Murphy, and E. Linney Retinoic acid receptor expression vector inhibits differentiation of F9 embryonal carcinoma cells Genes Dev. 3 1989 1647 1656
10. H. Weiler-Guettler, K. Yu, G. Soff, L.J. Gudas, and R.D. Rosenberg Thrombomodulin gene regulation by cAMP and retinoic acid in F9 embryonal carcinoma cells Proc. Natl. Acad. Sci. U. S. A. 89 1992 2155 2159
11. C.J. Sherr, and J.M. Roberts CDK inhibitors: positive and negative regulators of G1-phase progression Genes Dev. 13 1999 1501 1512
12. A. Vidal, and A. Koff Cell-cycle inhibitors: three families united by a common cause Gene 247 2000 1 15
13. G.P. Dotto p21(WAF1/Cip1): more than a break to the cell cycle? Biochim. Biophys. Acta 1471 2000 M43 M56
14. A.L. Gartel, and A.L. Tyner The role of the cyclin-dependent kinase inhibitor p21 in apoptosis Mol. Cancer Ther. 1 2002 639 649
15. O. Coqueret New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? Trends Cell Biol. 13 2003 65 70
16. J.A. Erhardt, and R.N. Pittman Ectopic p21(WAF1) expression induces differentiation-specific cell cycle changes in PC12 cells characteristic of nerve growth factor treatment J. Biol. Chem. 273 1998 23517 23523
17. J.A. Erhardt, and R.N. Pittman p21WAF1 induces permanent growth arrest and enhances differentiation, but does not alter apoptosis in PC12 cells Oncogene 16 1998 443 451
18. T. Casini, and P.G. Pelicci A function of p21 during promyelocytic leukemia cell differentiation independent of CDK inhibition and cell cycle arrest Oncogene 18 1999 3235 3243
19. G. Baldassarre, M.V. Barone, B. Belletti, C. Sandomenico, P. Bruni, S. Spiezia, A. Boccia, M.T. Vento, A. Romano, S. Pepe, A. Fusco, and G. Viglietto Key role of the cyclin-dependent kinase inhibitor p27kip1 for embryonal carcinoma cell survival and differentiation Oncogene 18 1999 6241 6251
20. J. Zezula, P. Casaccia-Bonnefil, S.A. Ezhevsky, D.J. Osterhout, J.M. Levine, S.F. Dowdy, M.V. Chao, and A. Koff p21cip1 is required for the differentiation of oligodendrocytes independently of cell cycle withdrawal EMBO Rep. 2 2001 27 34
21. Y. Negishi, N. Ui, M. Nakajima, K. Kawashima, K. Maruyama, T. Takizawa, and H. Endo p21Cip-1/SDI-1/WAF-1 gene is involved in chondrogenic differentiation of ATDC5 cells in vitro J. Biol. Chem. 276 2001 33249 33256
22. G. Redeuilh, A. Attia, J. Mester, and M. Sabbah Transcriptional activation by the oestrogen receptor alpha is modulated through inhibition of cyclin-dependent kinases Oncogene 21 2002 5773 5782
23. B.D. Chang, K. Watanabe, E.V. Broude, J. Fang, J.C. Poole, T.V. Kalinichenko, and I.B. Roninson Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases Proc. Natl. Acad. Sci. U. S. A. 97 2000 4291 4296
24. T.N. Faria, C. Mendelsohn, P. Chambon, and L.J. Gudas The targeted disruption of both alleles of RARbeta(2) in F9 cells results in the loss of retinoic acid-associated growth arrest J. Biol. Chem. 274 1999 26783 26788
25. R. Li, T.N. Faria, M. Boehm, E.G. Nabel, and L.J. Gudas Retinoic acid causes cell growth arrest and an increase in p27 in F9 wild type but not in F9 retinoic acid receptor beta2 knockout cells Exp. Cell Res. 294 2004 290 300
26. Y. Shirayoshi, S. Imada, S. Katayanagi, M. Uyeno, and M. Imada Cyclic AMP-mediated augmentation of thrombomodulin gene expression: cell type-dependent usage of control regions Exp. Cell Res. 208 1993 75 83
27. J. Chen, P. Saha, S. Kornbluth, B.D. Dynlacht, and A. Dutta Cyclin-binding motifs are essential for the function of p21CIP1 Mol. Cell. Biol. 16 1996 4673 4682
28. J.A. Wohlschlegel, B.T. Dwyer, D.Y. Takeda, and A. Dutta Mutational analysis of the Cy motif from p21 reveals sequence degeneracy and specificity for different cyclin-dependent kinases Mol. Cell. Biol. 21 2001 4868 4874
29. A.W. Snowden, L.A. Anderson, G.A. Webster, and N.D. Perkins A novel transcriptional repression domain mediates p21(WAF1/CIP1) induction of p300 transactivation Mol. Cell. Biol. 20 2000 2676 2686
30. J. Vachtenheim, and H. Novotna Expression of the aromatic L-amino acid decarboxylase mRNA in human tumour cell lines of neuroendocrine and neuroectodermal origin Eur. J. Cancer 33 1997 2411 2417
31. Y. Li, M.A. Glozak, S.M. Smith, and M.B. Rogers The expression and activity of D-type cyclins in F9 embryonal carcinoma cells: modulation of growth by RXR-selective retinoids Exp. Cell Res. 253 1999 372 384
32. M. Liu, A. Iavarone, and L.P. Freedman Transcriptional activation of the human p21(WAF1/CIP1) gene by retinoic acid receptor. Correlation with retinoid induction of U937 cell differentiation J. Biol. Chem. 271 1996 31723 31728
33. R.J. Sheaff, J.D. Singer, J. Swanger, M. Smitherman, J.M. Roberts, and B.E. Clurman Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination Mol. Cell 5 2000 403 410
34. A.B. Malashicheva, T.V. Kislyakova, N.D. Aksenov, K.A. Osipov, and V.A. Pospelov F9 embryonal carcinoma cells fail to stop at G1/S boundary of the cell cycle after gamma-irradiation due to p21WAF1/CIP1 degradation Oncogene 19 2000 3858 3865
35. A. Suzuki, Y. Tsutomi, M. Miura, and K. Akahane Caspase 3 inactivation to suppress Fas-mediated apoptosis: identification of binding domain with p21 and ILP and inactivation machinery by p21 Oncogene 18 1999 1239 1244
36. A. Suzuki, Y. Tsutomi, K. Akahane, T. Araki, and M. Miura Resistance to Fas-mediated apoptosis: activation of caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP Oncogene 17 1998 931 939
37. S.Q. Xu, and W.S. El-Deiry p21(WAF1/CIP1) inhibits initiator caspase cleavage by TRAIL death receptor DR4 Biochem. Biophys. Res. Commun. 269 2000 179 190
38. B.P. Zhou, Y. Liao, W. Xia, B. Spohn, M.H. Lee, and M.C. Hung Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells Nat. Cell Biol. 3 2001 245 252
39. A. Suzuki, H. Kawano, M. Hayashida, Y. Hayasaki, Y. Tsutomi, and K. Akahane Procaspase 3/p21 complex formation to resist fas-mediated cell death is initiated as a result of the phosphorylation of p21 by protein kinase A Cell Death Differ. 7 2000 721 728
40. D.J. Gregory, E. Garcia-Wilson, J.C. Poole, A.W. Snowden, I.B. Roninson, and N.D. Perkins Induction of transcription through the p300 CRD1 motif by p21WAF1/CIP1 is core promoter specific and cyclin dependent kinase independent Cell Cycle 1 2002 343 350
41. D. Girdwood, D. Bumpass, O.A. Vaughan, A. Thain, L.A. Anderson, A.W. Snowden, E. Garcia-Wilson, N.D. Perkins, and R.T. Hay P300 transcriptional repression is mediated by SUMO modification Mol. Cell 11 2003 1043 1054
42. T.N. Faria, G.J. LaRosa, E. Wilen, J. Liao, and L.J. Gudas Characterization of genes which exhibit reduced expression during the retinoic acid-induced differentiation of F9 teratocarcinoma cells: involvement of cyclin D3 in RA-mediated growth arrest Mol. Cell. Endocrinol. 143 1998 155 166
43. H. Kaufmann, R. Marone, M.A. Olayioye, J.E. Bailey, and M. Fussenegger Characterization of an N-terminally truncated cyclin A isoform in mammalian cells J. Biol. Chem. 276 2001 29987 29993
44. M. Anger, V. Bryja, L. Jirmanova, A. Hampl, M. Carrington, J. Motlik, P. Dvorak, and M. Kubelka The appearance of truncated cyclin A2 correlates with differentiation of mouse embryonic stem cells Biochem. Biophys. Res. Commun. 302 2003 825 830
45. J. Bastien, S. Adam-Stitah, J.L. Plassat, P. Chambon, and C. Rochette-Egly The phosphorylation site located in the A region of retinoic X receptor alpha is required for the antiproliferative effect of retinoic acid (RA) and the activation of RA target genes in F9 cells J. Biol. Chem. 277 2002 28683 28689
46. G. Baldassarre, A. Boccia, P. Bruni, C. Sandomenico, M.V. Barone, S. Pepe, T. Angrisano, B. Belletti, M.L. Motti, A. Fusco, and G. Viglietto Retinoic acid induces neuronal differentiation of embryonal carcinoma cells by reducing proteasome-dependent proteolysis of the cyclin- dependent inhibitor p27 Cell Growth Differ. 11 2000 517 526
47. P. Niforas, G.M. Sanderson, C.H. Bird, and P. Bird Characterization of the mouse thrombomodulin gene and functional analysis of the 5′ flanking region in F9 teratocarcinoma cells Biochim. Biophys. Acta 1173 1993 179 187
48. P. Niforas, M.D. Chu, and P. Bird A retinoic acid/cAMP-responsive enhancer containing a cAMP responsive element is required for the activation of the mouse thrombomodulin-encoding gene in differentiating F9 cells Gene 176 1996 139 147
49. E. Korzus, J. Torchia, D.W. Rose, L. Xu, R. Kurokawa, E.M. McInerney, T.M. Mullen, C.K. Glass, and M.G. Rosenfeld Transcription factor-specific requirements for coactivators and their acetyltransferase functions Science 279 1998 703 707
50. N. Vo, and R.H. Goodman CREB-binding protein and p300 in transcriptional regulation J. Biol. Chem. 276 2001 13505 13508
51. B. Mayr, and M. Montminy Transcriptional regulation by the phosphorylation-dependent factor CREB Nat. Rev., Mol. Cell Biol. 2 2001 599 609
52. M. Ota, K. Eto, Y. Ninomiya, and M. Ikeda Accumulation of p300 mediates transcriptional repression of simian virus 40 enhancer in undifferentiated F9 embryonal carcinoma cells Cell Growth Differ. 9 1998 989 997
53. F. Brouillard, and C.E. Cremisi Concomitant increase of histone acetyltransferase activity and degradation of p300 during retinoic acid-induced differentiation of F9 cells J. Biol. Chem. 278 2003 39509 39516
54. S. Kawata, Y. Ariumi, and K. Shimotohno p21(Waf1/Cip1/Sdi1) prevents apoptosis as well as stimulates growth in cells transformed or immortalized by human T-cell leukemia virus type 1-encoded tax J. Virol. 77 2003 7291 7299
55. M.V. Blagosklonny Are p27 and p21 cytoplasmic oncoproteins? Cell Cycle 1 2002 391 393
56. R.H. Weiss p21Waf1/Cip1 as a therapeutic target in breast and other cancers Cancer Cell 4 2003 425 429